Ligand Pharmaceuticals
LGND
#2805
Rank
A$8.61 B
Marketcap
A$431.92
Share price
2.31%
Change (1 day)
53.37%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$1.74 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are A$1.74 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.81 B353.27%
2024-12-31A$0.17 B41.3%
2023-12-31A$0.12 B-47.81%
2022-12-31A$0.24 B-63.06%
2021-12-31A$0.65 B-22.59%
2020-12-31A$0.84 B-18.32%
2019-12-31A$1.03 B4.61%
2018-12-31A$0.99 B207.33%
2017-12-31A$0.32 B0.99%
2016-12-31A$0.32 B3.11%
2015-12-31A$0.31 B8.75%
2014-12-31A$0.28 B362.12%
2013-12-31A$61.77 M-17.46%
2012-12-31A$74.84 M-31.73%
2011-12-31A$0.10 B38.48%
2010-12-31A$79.15 M-48.49%
2009-12-31A$0.15 B-40.36%
2008-12-31A$0.25 B56.28%
2007-12-31A$0.16 B-56.48%
2006-12-31A$0.37 B-34.77%
2005-12-31A$0.58 B10.24%
2004-12-31A$0.52 B11.4%
2003-12-31A$0.47 B32.32%
2002-12-31A$0.35 B4.05%
2001-12-31A$0.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$166.13 B 9,428.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$165.49 B 9,391.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$155.13 B 8,797.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$120.14 B 6,790.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$19.48 B 1,017.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$125.67 B 7,107.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$93.47 B 5,260.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$84.50 B 4,746.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
A$0.11 B-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA